U.S. Online Retail and Ecommerce Stock News

BWX Technologies (NYSE:BWXT) is expected to deliver annual earnings growth of 10.8% and revenue growth of 8.7%. These rates trail the broader US market averages of 16% and 10.5%, respectively. Net profit margins sit at 10%, marking a slight dip from last year’s 10.3%. Notably, the company’s earnings have jumped 10.9% over the past year compared to a five-year average of just 0.2% per year. With the stock trading well above the fair value estimate and at a price-to-earnings ratio higher than...

Apple Hospitality REIT (APLE) delivered mixed results in its latest earnings, with a notable reversal in momentum from previous years. Net profit margins declined to 12.4% compared to last year’s 14.5%, and the company posted negative earnings growth over the past twelve months after growing earnings by 49.5% annually over the last five years. Looking ahead, management expects revenue to rise just 1.8% per year and earnings to grow at 0.7%, both lagging the broader US market. This may weigh...

Douglas Dynamics (PLOW) posted a net profit margin of 6.6%, down from 9.7% last year, ending a five-year run of strong profitability gains that saw average annual earnings growth of 45.8%. Revenue is projected to rise by 6.5% annually, trailing the broader US market's 10.5% pace. Expected EPS growth of 14.7% also lags behind the 16% market forecast. Investors are likely to view these results as a sign of recent margin pressure. However, with shares trading below fair value and analyst...

PotlatchDeltic (PCH) delivered a sharp turnaround in profitability this quarter, with its net profit margin climbing to 5.8%, up from just 1.6% a year ago, and earnings rising 288.4% year-over-year. This is far stronger than its five-year average, which saw earnings declining 38.9% per year. Looking ahead, the company is forecasting annual earnings growth of 17.9%, set to outpace the broader US market, while management values shares below their estimated fair value at $38.95. These improving...

ThredUp (TDUP) remains unprofitable, but revenue is forecast to grow at 10.8% per year, while losses have narrowed by 14.8% annually over the past five years. With a Price-to-Sales Ratio of 3.4x, the stock trades well above the US Specialty Retail industry average of 0.4x and the peer average of 1.1x. While margins are still negative, ongoing top-line growth combined with improving losses gives investors reasons to keep an eye on the company’s progress. See our full analysis for ThredUp. Now...

Boise Cascade (BCC) reported annual earnings growth of 17.5%, outpacing the broader US market forecast of 16%. However, revenue is projected to grow at just 3.3% per year, trailing the US average of 10.5%. Net profit margins declined to 3%, down from 6% the previous year. The company has seen average annual earnings decrease by 6.3% over the last five years. Despite the recent dip in profitability and ongoing margin compression, analysts expect stronger profit growth ahead, and BCC currently...

JELD-WEN Holding (JELD) posted another unprofitable quarter, with both its earnings and net profit margin remaining in the red. Over the last five years, losses have widened at a staggering 78.1% per year. The company is projected to swing to profitability within the next three years as earnings are forecast to surge 131.26% per year. Despite slow anticipated revenue growth of just 1.9% annually, the stock trades at a price-to-sales multiple of just 0.1x, far lower than industry and peer...

Atlas Energy Solutions (AESI) remains unprofitable, but it has narrowed its losses by 2.7% per year over the past five years. While margins have yet to turn positive and fresh figures on recent profitability are not available, earnings are forecast to surge by 110.88% annually. This may put the company on track for potential profitability within three years, which is well ahead of market averages. With revenue expected to grow at only 2.2% per year compared to the broader US market's 10.5%,...

Federal Agricultural Mortgage (AGM) posted net profit margins of 50.9%, edging up from last year’s 49%. Over the past five years, AGM has averaged 14.2% annual earnings growth, and most recently, earnings climbed 13.1%. Looking ahead, earnings are projected to rise about 8% per year, a pace that trails the wider US market's expected 16% annual growth. Revenue growth is anticipated to slightly outperform at 10.8% per year compared to the US market’s 10.5%. See our full analysis for Federal...

James River Group Holdings (JRVR) posted a continued loss, with the company’s losses increasing at an average rate of 2.3% per year over the past five years. Looking ahead, analysts expect earnings to rebound sharply and are forecasting annual growth of 88.79% with a return to profitability within three years. With relative value compared to peers and the prospect of rapid earnings improvement, investors may see reasons for optimism despite a challenging recent track record. See our full...

Super Group (SGHC) posted a striking surge in net profit margins, coming in at 9.8% compared to just 0.3% last year. This improvement was fueled by an extraordinary 4,994.9% earnings growth over the same period. Looking ahead, the company’s earnings are expected to grow 32.2% per year, far outpacing the broader US market’s forecast of 16% per year. Revenue is projected to rise by 9.2% annually, just below the US average of 10.5%. With these numbers, investors are seeing a notable turnaround...

Exact Sciences (EXAS) remains unprofitable, with losses increasing at an average pace of 1.5% per year over the past five years. Supported by a revenue growth forecast of 10.4% per year and projected earnings acceleration of 89.51% per year, the company is expected to reach profitability within three years, a faster turnaround than the broader market. Investors are likely to focus on the stock’s strong relative and absolute value metrics, as well as anticipated profit and revenue gains, even...

Armada Hoffler Properties (AHH) recently reported figures that point to a turning point, with revenue expected to decline by 10.1% per year over the next three years, even as earnings are forecast to grow at a brisk 21.8% annually. The company has just turned profitable and logged a major one-off gain of $27.2 million in the last 12 months. Despite a five-year track record of earnings declining by 16.1% per year, management now foresees a sharp rebound in bottom-line performance. This sets up...

Voyager Technologies (VOYG) remains unprofitable, with no established year-on-year earnings trend so far, as the company has been publicly traded for less than three years. Revenue is forecast to surge 51.5% per year, far outpacing the US market average of 10.5%. However, net margins remain negative and the Price-To-Sales Ratio sits at a steep 10.3x, well above industry and peer benchmarks. With investors focused on whether overhead and costs are being effectively controlled, the company’s...

Addus HomeCare (ADUS) delivered earnings growth of 16.3% over the past year, with a robust five-year compound annual growth rate for earnings of 19.4%. Earnings are forecast to keep climbing at 16.4% per year, outpacing the broader US market average forecast, while net profit margins held steady at 6.4% compared to 6.5% a year ago. Although revenue growth is set to lag the wider market at 7.8% annually, the company’s consistent track record of profitability and favorable valuation relative to...

Syndax Pharmaceuticals (SNDX) remains unprofitable as net losses have widened at 41.3% per year over the past five years. Net profit margins have stayed negative with no track record of high-quality earnings. Looking forward, revenue is forecast to climb 40.4% annually, outpacing the US market. Earnings are projected to surge 72.8% per year with profitability expected within three years. The share price has settled at $15.35, notably below its estimated fair value of $214.76. The company...

Vornado Realty Trust (VNO) has turned profitable, posting a robust 46.1% per year earnings growth rate over the last five years, but recent results were boosted by a one-off gain of $827.3 million. Although net profit margins have moved into positive territory, forecasts now call for earnings to drop sharply by 83.8% per year over the coming three years. Revenue is projected to rise at a slower 3.3% per year, which is behind the broader US market’s 10.5% per year expectation. With profits...

Kontoor Brands (KTB) is forecasting impressive earnings growth of 20.9% per year, outpacing the US market average of 16%. Current net profit margins have compressed to 7.7% from last year's 9.7%, and over the past five years, the company has averaged 12.4% annual earnings growth, despite recent negative momentum. With top-line growth likely but near-term margin pressure evident, investors are weighing this strong outlook against recent softness in profitability. See our full analysis for...

Harmonic (HLIT) reported a net profit margin of 7.8%, down from 13.6% the previous year, highlighting a decline in profitability. Despite this margin pressure, the company’s revenue is forecast to grow at 8.6% annually, which is slower than the broader US market’s 10.5%. While earnings growth over the last year was negative, Harmonic has posted an impressive 48.6% annualized earnings growth rate over the past five years, demonstrating substantial long-term gains. Looking forward, earnings are...

Ever wondered if Alight could be a hidden gem or is already priced to perfection? If you’re on the hunt for value, you might be surprised by what the numbers reveal. It's been a rollercoaster for Alight’s shareholders. They have seen the stock drop 12.3% in the last week and a staggering 60.0% since the start of the year, signaling a big shift in how the market values the business. Recently, Alight made headlines by entering new partnerships that aim to strengthen its position in the...

CytomX Therapeutics announced it will present initial translational data from its ongoing Phase 1 study of CX-801 in advanced melanoma at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, scheduled for November 7-9, 2025, in National Harbor, MD. This upcoming clinical update provides stakeholders with a key opportunity to assess the potential of CytomX's immunotherapy pipeline, possibly shaping future expectations around its development progress and clinical...

BioNTech (BNTX) remains unprofitable, with net losses increasing at an annual rate of 22.1% over the past five years. While revenue is projected to grow just 1.7% per year, which is much slower than the broader US market's 10.5% rate, the company is expected to stay in the red for at least the next three years. Investors may take note of BioNTech trading below analyst price targets, but persistent weak margins and muted growth expectations continue to cloud the overall outlook. See our full...

Wondering if SPS Commerce is a hidden bargain or a value trap? Here is a breakdown of what’s going on with this software stock before you decide whether it deserves a spot on your radar. The stock has caught plenty of attention after plunging by 25.6% this week and over 54% year-to-date. You may be wondering if this volatility hints at risk, opportunity, or both. Recent news around sector-wide shifts in software demand and emerging competitive pressures have added fuel to the fire. Investors...

Sealed Air Corporation recently reported third-quarter 2025 earnings, highlighting a substantial increase in net income to US$255.1 million and diluted earnings per share to US$1.73, compared to the same period last year, with sales remaining largely unchanged at US$1.35 billion. This performance suggests operational efficiencies are compensating for flat revenue, as the company also reaffirmed its full-year earnings guidance despite continued volume pressures in several segments. We’ll...